HMGCR and myopathy: Recently, the pathogenicity of anti-HMGCR was demonstrated [13–15], and during the 224th European Neuromuscular Centre (ENMC) International Workshop [16], in the presence of proximal weakness and elevated CK levels, anti-HMGCR myopathy was defined.